Kiromic Biopharma, Inc. Interest Expense
Kiromic Biopharma, Inc. reported Interest Expense of $166.50 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-04-17
- Kiromic Biopharma, Inc. interest expense for the quarter ending 2022-12-31 was $159.60K, a 2605.08% increase year-over-year.
- Kiromic Biopharma, Inc. interest expense for the quarter ending 2022-09-30 was $1.40K, a 180.00% increase year-over-year.
- Kiromic Biopharma, Inc. interest expense for the quarter ending 2022-06-30 was $2.70K, a 28.57% increase year-over-year.
- Kiromic Biopharma, Inc. interest expense for the quarter ending 2022-03-31 was $2.80K, a 24.32% decline year-over-year.
- Kiromic Biopharma, Inc. interest expense for fiscal 2022 was $166.50K, a 1264.75% increase from fiscal 2021.
- Kiromic Biopharma, Inc. interest expense for fiscal 2021 was $12.20K, a 269.70% increase from fiscal 2020.
- Kiromic Biopharma, Inc. interest expense for fiscal 2020 was $3.30K, a 85.33% decline from fiscal 2019.
- Kiromic Biopharma, Inc. interest expense for fiscal 2019 was $22.50K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $159.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $161.00K derived: sum of 2 quarters · filed 2023-04-17 | $163.70K derived: sum of 3 quarters · filed 2023-04-17 | $166.50K 10-K · filed 2023-04-17 |
| 2022-09-30 | $1.40K 10-Q · filed 2022-11-14 | $4.10K derived: sum of 2 quarters · filed 2022-11-14 | $6.90K 10-Q · filed 2022-11-14 | $12.80K derived: sum of 4 quarters · filed 2023-04-17 |
| 2022-06-30 | $2.70K 10-Q · filed 2022-08-12 | $5.50K 10-Q · filed 2022-08-12 | $11.40K derived: sum of 3 quarters · filed 2023-04-17 | $11.90K derived: sum of 4 quarters · filed 2023-04-17 |
| 2022-03-31 | $2.80K 10-Q · filed 2022-05-13 | $8.70K derived: sum of 2 quarters · filed 2023-04-17 | $9.20K derived: sum of 3 quarters · filed 2023-04-17 | $11.30K derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-12-31 | $5.90K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $6.40K derived: sum of 2 quarters · filed 2023-04-17 | $8.50K derived: sum of 3 quarters · filed 2023-04-17 | $12.20K 10-K · filed 2023-04-17 |
| 2021-09-30 | $500.00 10-Q · filed 2022-11-14 | $2.60K derived: sum of 2 quarters · filed 2022-11-14 | $6.30K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $2.10K 10-Q · filed 2022-08-12 | $5.80K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $3.70K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $3.30K 10-K · filed 2022-04-08 | |||
| 2019-12-31 | $100.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $7.50K derived: sum of 2 quarters · filed 2021-03-31 | $22.50K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $7.40K 10-Q · filed 2020-11-30 | $22.40K 10-Q · filed 2020-11-30 |